bioAffinity Technologies, Inc. (BIAF)
2.15
+0.22
(+11.40%)
USD |
NASDAQ |
Nov 18, 16:00
2.08
-0.07
(-3.26%)
After-Hours: 20:00
bioAffinity Technologies Price : 2.15 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 1.94 | 2.28 | 1.94 | 2.15 | 70499.00 |
| Nov 17, 2026 | 1.99 | 2.053 | 1.90 | 1.93 | 68072.00 |
| Nov 16, 2026 | 2.125 | 2.132 | 1.96 | 2.00 | 74099.00 |
| Nov 13, 2026 | 2.342 | 2.350 | 2.17 | 2.20 | 51554.00 |
| Nov 12, 2026 | 2.43 | 2.45 | 2.290 | 2.34 | 48526.00 |
| Nov 11, 2026 | 2.37 | 2.60 | 2.23 | 2.425 | 76416.00 |
| Nov 10, 2026 | 2.39 | 2.49 | 2.37 | 2.39 | 82080.00 |
| Nov 09, 2026 | 2.65 | 2.90 | 2.25 | 2.26 | 101644.0 |
| Nov 06, 2026 | 2.62 | 2.824 | 2.62 | 2.715 | 24832.00 |
| Nov 05, 2026 | 2.96 | 2.971 | 2.541 | 2.60 | 76814.00 |
| Nov 04, 2026 | 3.11 | 3.22 | 2.93 | 2.93 | 52564.00 |
| Nov 03, 2026 | 2.99 | 3.20 | 2.965 | 3.19 | 98862.00 |
| Nov 02, 2026 | 2.84 | 3.056 | 2.84 | 2.99 | 90283.00 |
| Oct 30, 2026 | 3.04 | 3.04 | 2.861 | 2.91 | 47270.00 |
| Oct 29, 2026 | 3.02 | 3.29 | 2.99 | 3.03 | 326520.0 |
| Oct 28, 2026 | 2.914 | 3.16 | 2.84 | 3.14 | 55804.00 |
| Oct 27, 2026 | 2.81 | 3.140 | 2.75 | 2.96 | 189364.0 |
| Oct 26, 2026 | 2.80 | 2.88 | 2.66 | 2.83 | 70476.00 |
| Oct 23, 2026 | 3.17 | 3.265 | 2.80 | 2.80 | 127027.0 |
| Oct 22, 2026 | 3.50 | 3.73 | 3.14 | 3.17 | 90624.00 |
| Oct 21, 2026 | 3.68 | 3.690 | 3.54 | 3.57 | 64795.00 |
| Oct 20, 2026 | 3.44 | 3.75 | 3.44 | 3.66 | 89086.00 |
| Oct 19, 2026 | 3.67 | 3.69 | 3.43 | 3.51 | 72982.00 |
| Oct 16, 2026 | 3.95 | 3.95 | 3.60 | 3.73 | 101847.0 |
| Oct 15, 2026 | 3.47 | 4.10 | 3.406 | 3.96 | 278094.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 13.62 |
| Perspective Therapeutics, Inc. | 0.7801 |
| MiMedx Group, Inc. | 3.18 |
| Veracyte, Inc. | 25.57 |
| T2 Biosystems, Inc. | 0.0006 |
Price Related Metrics
| PS Ratio | 0.1794 |
| Price to Book Value | 0.6407 |
| Earnings Yield | -1.77K% |
| Market Cap | 2.508M |